Vanguard Discloses 6.09% Stake in Pacific Biosciences

TL;DR

**Vanguard still holds a big chunk of Pacific Biosciences, showing they're in it for the long haul.**

AI Summary

The Vanguard Group, a major investment firm, filed an amended Schedule 13G/A on January 10, 2024, indicating its ownership of 16,063,056 shares of Common Stock in Pacific Biosciences of California Inc. as of December 29, 2023. This represents a 6.09% passive ownership stake in the company. This filing matters to investors because it shows that a large institutional investor like Vanguard maintains a significant, albeit slightly reduced, position in Pacific Biosciences, signaling continued confidence in the company's long-term prospects.

Why It Matters

This filing confirms Vanguard's continued significant, passive investment in Pacific Biosciences, which can be seen as a vote of confidence from a major institutional investor.

Risk Assessment

Risk Level: low — This filing is routine and indicates a passive investment by a large institutional investor, posing minimal direct risk.

Analyst Insight

Smart investors should note that a large, passive institutional investor like Vanguard continues to hold a substantial stake, suggesting long-term confidence in Pacific Biosciences, but this filing alone doesn't indicate any immediate catalysts for price movement.

Key Numbers

• 16,063,056 — Shares Beneficially Owned (Represents the total number of Common Stock shares of Pacific Biosciences held by The Vanguard Group as of December 29, 2023.)
• 6.09% — Percentage of Class (Indicates the percentage of Pacific Biosciences' Common Stock that The Vanguard Group beneficially owns, showing a significant institutional stake.)

Key Players & Entities

• The Vanguard Group (company) — reporting person and institutional investor
• Pacific Biosciences of California Inc. (company) — issuer of the securities
• 16,063,056 (dollar_amount) — number of shares beneficially owned by Vanguard
• 6.09% (dollar_amount) — percentage of class beneficially owned by Vanguard
• December 29, 2023 (date) — date of event requiring the filing

Forward-Looking Statements

• Vanguard will maintain a significant, passive stake in Pacific Biosciences for the foreseeable future. (The Vanguard Group) — high confidence, target: 2025-12-31

FAQ

Filing Documents

• tv0020-pacificbiosciencesofc.htm (SC 13G/A) — 11KB
• 0001104659-24-002867.txt ( ) — 13KB

(a) - Name of Issuer

Item 1(a) - Name of Issuer: Pacific Biosciences of California Inc

(b) - Address of Issuer's Principal Executive Offices

Item 1(b) - Address of Issuer's Principal Executive Offices: 1305 O'Brien Drive Menlo Park, CA 94025

(a) - Name of Person Filing

Item 2(a) - Name of Person Filing: The Vanguard Group - 23-1945930

(b) – Address of Principal Business Office or, if none, residence

Item 2(b) – Address of Principal Business Office or, if none, residence: 100 Vanguard Blvd. Malvern, PA 19355

(c) – Citizenship

Item 2(c) – Citizenship: Pennsylvania

(d) - Title of Class of Securities

Item 2(d) - Title of Class of Securities: Common Stock

(e) - CUSIP Number

Item 2(e) - CUSIP Number 69404D108

- Type of Filing

Item 3 - Type of Filing: This statement is being filed pursuant to Rule 13d-1. An investment adviser in accordance with 240.13d-1(b)(1)(ii)(E).

- Ownership

Item 4 - Ownership: (a) Amount Beneficially Owned: (b) Percent of Class: (c) Number of shares as to which such person has: (i) sole power to vote or direct to vote: (ii) shared power to vote or direct to vote: (iii) sole power to dispose of or to direct the disposition of: (iv) shared power to dispose or to direct the disposition of: Comments: The responses to questions 5 through 9 and 11 on the cover page(s) are incorporated by reference into this Item 4.

- Ownership of Five Percent or Less of a Class

Item 5 - Ownership of Five Percent or Less of a Class: If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than 5 percent of the class of securities, check the following

- Ownership of More Than Five Percent on Behalf of Another Person

Item 6 - Ownership of More Than Five Percent on Behalf of Another Person: The Vanguard Group, Inc.'s clients, including investment companies registered under the Investment Company Act of 1940 and other managed accounts, have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the securities reported herein. No one other person's interest in the securities reported herein is more than 5%. Item 7 - Identification and Classification of the Subsidiary Which Acquired The Security Being Reported on by the Parent Holding Company: Not applicable

- Identification and Classification of Members of Group

Item 8 - Identification and Classification of Members of Group: Not applicable

- Notice of Dissolution of Group

Item 9 - Notice of Dissolution of Group: Not applicable

- Certification

Item 10 - Certification: By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under 240.14a-11. Signature After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Date: January 10, 2024 By /s/ Ashley Grim Name: Ashley Grim Title: Head of Global Fund Administration

View Full Filing

View this SC 13G/A filing on SEC EDGAR